AASS-IN-1 is a 2-aminoadipic semialdehyde synthase (AASS) inhibitor with a human IC50 of 142 µM. AASS-IN-1 inhibits AASS activity by binding to the LOR domain of AASS. AASS-IN-1 can be used for the research of glutaric aciduria type 1[1].
Molecular Weight:
309.79
Purity:
98.40
Formula:
C15H20ClN3O2
Target:
Others
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted